Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

No further studies are currently required according to REACH Annex IX and X as the substance is not classified as a mutagen and data available from repeated dose study(ies) of the main constituents do not indicate that the substance is able to induce hyperplasia and/or preneoplastic lesions.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

No further studies are currently required according to REACH Annex IX and X as the substance is not classified as a mutagen and data available from repeated dose study(ies) of the main constituents do not indicate that the substance is able to induce hyperplasia and/or preneoplastic lesions. In lack of positive information for carcinogenic effects, the substance is not required to be labelled for carcinogenicity according to CLP (Regulation EU 1272/2008).